CPTx

CPTx (Composite Programmable Therapeutics) is a biotechnology company pioneering a new paradigm in therapeutic discovery and development. Building on patented DNA nanofabrication technology and AI-driven design, CPTx develops composite nanoagents for cellular precision and multivalent targeting, with an owned portfolio of drug candidates ranging from antivirals to genetic medicines.